glp-1 agonists pill Pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss? Everything You Need to Know

Genetically-predicted GLP1R expression (the target of GLP-1 RAs) showed an inverse association with background [odds ratio (OR)=0.83, 95% CI, 0.710.97] and severe nonproliferative DR (OR=0.72, 95% CI, 0.530.98), and a non-significant association with overall (OR=0.97, 95% CI, 0.921.03) and proliferative DR (OR=0.98, 95% CI, 0.911.05)

Clinical studies have demonstrated that retatrutide can reduce markers of inflammation, such as C-reactive protein (CRP), which are associated with an increased risk of cardiovascular events

Several factors should be considered such as magnitude of HbA1c reduction, effect on weight loss and adverse effect rate (34)

Other distinct GLP-1 agonists include tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), and liraglutide (Saxenda, Victoza)

Cell studies show that BPA exposure directly causes a decrease in GLP-1 and insulin release through miR-338.[ref][ref] Related article: BPA, BPS, Genetics, and Detoxification Recap of your genes: FAQs: Do genetics affect how well semaglutide works

Eli Lilly announced Phase 3 ATTAIN-1 trial results for orforglipron, an oral GLP-1 receptor agonist, showing significant weight loss in adults with obesity or overweight without diabetes